List view / Grid view
3 May 2016 | By Victoria White, Digital Content Producer
The EC has granted orphan medicinal product designation to Medidur for the treatment of chronic non-infectious uveitis of the posterior of the eye...
13 July 2015 | By Victoria White
pSivida has announced positive top-line results from a Phase II investigator-sponsored study of Medidur for uveitis affecting the posterior of the eye...
19 May 2015 | By Victoria White
pSivida has announced positive safety data from its ongoing assessment of safety data from its Phase III clinical trial of Medidur for posterior uveitis...
2 April 2015 | By Victoria White
pSivida has announced the completion of the targeted enrollment of 120 patients in its pivotal Phase III clinical trial of Medidur for posterior uveitis...
27 July 2012 | By pSivida Corp.
For the treatment of vision impairment associated with chronic diabetic macular edema...
13 May 2011 | By pSivida Corp.
A New Drug Application for the investigational drug ILUVIEN® for the treatment of diabetic macular edema (DME) has been resubmitted...
